Business
Why the ResApp (ASX:RAP) share price is edging higher
ResApp Health Ltd (ASX: RAP) shares are edging higher today after the company updated the market on its recent meeting with the United States Food and Drug Administration (FDA) for SleepCheck. In the minutes after market open, the ResApp share price reached an intra-day high of 9.3 cents but have partially retreated. At the time of writing, the ResApp share price is trading 2.22% higher at 9.2 cents.
What’s driving the ResApp share price?
The ResApp share price is on the move today after the company advised it has received a clear path to gain regulatory approval for its SleepCheck app to be used in the United States.
ResApp will pursue a 510(k) regulatory pathway for SleepCheck as a prescription only device. The 510(k) approach…
-
Noosa News12 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News22 hours agoStore-bought bee hotels doing more harm than good for native species
-
Noosa News23 hours agoBilly Slater’s lack of options for Maroons players for State of Origin a blessing and a curse
-
Noosa News17 hours agoMan who allegedly stole children’s underwear charged with 28 offences